Early Intervention of the PKC-Hippo Signaling Alleviates Post-Traumatic Osteoarthritis
RNA-seq (gene expression) · mouse · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 36 samples: 12 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE294777_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1249407 and SRA study SRP577971. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 36 samples.
How we read this: 12 replicated groups read from 36 sample titles; they account for 36 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8919377 Sham1 Sham
- GSM8919378 Sham2 Sham
- GSM8919379 Sham3 Sham
- GSM8919380 ACL1 ACL
- GSM8919381 ACL2 ACL
- GSM8919382 ACL3 ACL
- GSM8919383 ACL_PKCi1 ACL_PKCi
- GSM8919384 ACL_PKCi2 ACL_PKCi
- GSM8919385 ACL_PKCi3 ACL_PKCi
- GSM9855227 0h_1 0h
- GSM9855228 0h_2 0h
- GSM9855229 0h_3 0h
- GSM9855230 7h_1 7h
- GSM9855231 7h_2 7h
- GSM9855232 7h_3 7h
- GSM9855233 72h_1 72h
- GSM9855234 72h_2 72h
- GSM9855235 72h_3 72h
- GSM9855236 C_1 C
- GSM9855237 C_2 C
- GSM9855238 C_3 C
- GSM9855239 PKCi_1 PKCi
- GSM9855240 PKCi_2 PKCi
- GSM9855241 PKCi_3 PKCi
- GSM9855242 LATSi_1 LATSi
- GSM9855243 LATSi_2 LATSi
- GSM9855244 LATSi_3 LATSi
- GSM9855245 Y/Ti_1 Y/Ti
- GSM9855246 Y/Ti_2 Y/Ti
- GSM9855247 Y/Ti_3 Y/Ti
- GSM9855248 PKC+Y/Ti_1 PKC+Y/Ti
- GSM9855249 PKC+Y/Ti_2 PKC+Y/Ti
- GSM9855250 PKC+Y/Ti_3 PKC+Y/Ti
- GSM9855251 LATS+Y/Ti_1 LATS+Y/Ti
- GSM9855252 LATS+Y/Ti_2 LATS+Y/Ti
- GSM9855253 LATS+Y/Ti_3 LATS+Y/Ti
- GSE290235 Fibrogenic gene signature as early prediction for the efficacy of pharmacological interventions for MASH-associated fibrosis, part1 32 samples shares intervention, early
- GSE290237 Fibrogenic gene signature as early prediction for the efficacy of pharmacological interventions for MASH-associated fibrosis, part2 32 samples shares intervention, early
- GSE300922 Xin-Zi-Sheng-Wan Decoction Alleviates Hyperuricemia-Induced Renal Injury by Modulating SPP1-CD44-Mediated Macrophage Infiltration and SRC/FAK/β-Catenin Signaling Pathway 12 samples shares alleviates
- GSE333173 Ketogenic Diet Alleviates Acute Radiation-Induced Intestinal Injury through JAK2/STAT3/RORγt/IL-17A Signaling Pathway via Gut Microbiome 9 samples shares alleviates
- GSE328666 Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway 9 samples shares alleviates
- GSE325353 Butyrylcholinesterase alleviates hepatic stellate cell activation via paracrine muscarinic signaling [2W-CCL4-DOX-HSC] 6 samples shares alleviates
- GSE269493 Hepatoprotective effects of late-stage clinical drug candidates and dietary intervention in the non-obese CDAA-HFD mouse model of advanced MASH with progressive fibrosis 81 samples shares intervention
- GSE338580 Transcriptomic profiling of mouse aging soleus muscles and drug interventions 78 samples shares intervention
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.